VEGF, the most potent proangiogenic factor (12), promotes endothelial cell proliferation and tumor angiogenesis by acting on specific tyrosine kinase receptors and VEGF receptors 1 and 2, facilitating tumor growth. The gene discussed is VEGFA; the disease is neoplasm.